At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Description
BMS is seeking to recruit a Manager, Cell Therapy Site Procurement located at the Bothell manufacturing facility (Seattle, WA area). Reporting to the Director, Cell Therapy Strategic Sourcing & Procurement, this role will be responsible for sourcing efforts for Direct manufacturing materials and & Indirect products and services. This position will maintain strong alignment to the Cell Therapy Development and Operations (CTDO) strategy and initiatives, support the business with close partnership with the CTDO Bothell site management team, and engage closely with other sites within the CTDO network. The Manager, Cell Therapy Site Procurement must display excellent communication skills to all internal stakeholders, senior leadership and suppliers.
Key responsibilities will include:
* Maintain continuity of current Good Manufacturing Procedures (cGMP) Direct material supply for manufacturing operations at the CTDO Bothell facility by managing suppliers and engaging directly with site stakeholders as well as global teams.
* Support launch and tech transfer activities at the CTDO site for new cell therapy assets
* Partner with Global Supply Chain Planning, Site Materials Management, Warehouse, Manufacturing and Quality teams to ensure supply base is meeting requirements of the CTDO operations
* Achieve and exceed value capture and savings, purchase price variance (PPV), invoicing compliance, and other procurement metrics.
* Lead Supplier Relationship Management programs as requested and aligned with Category Leads.
* Lead Regional sub-category strategy development and execution in conjunction with relevant category lead.
* Support and lead specific equipment and engineering projects as appropriate.
* Work on contracts, SOWs, LOIs, CDAs and other legal documentation leading the local or regional activity and supporting at a global level.
* Lead procurement risk management activities at the site in partnership with Category Leads and cross-functional teams.
* Develops effective relationships with key suppliers in a way that builds mutual respect, trust and drives performance in a manner consistent with the BMS values.
Provide Supplier Diversity vision and strategic direction for the site, leads Diversity initiatives & publishes diversity metrics and measures performance
Communication & Reporting Expectations:
* Incumbent is expected to perform with minimal supervision. Weekly/monthly status reports are provided to the Director, Cell Therapy Strategic Sourcing & Procurement
* Daily contacts with CTDO Bothell Site Leaders and site teams (Manufacturing, Quality, MSAT, Supply Chain) and CTDO Global teams
* Frequent contact with SS&P Category Leaders and Supplier Diversity Leaders
Essential experience and behaviors:
* Required: Bachelors Degree in Engineering, Science, or Business (Graduate Degree preferred)
* At least 6-8 years of cGMP experience in procurement or external manufacturing (cell therapy, biopharmaceuticals, pharmaceuticals, and/or medical device industry strongly preferred)
* Commercialization experience in fast-paced GMP start-up, breakthrough designation product launch or similar drug launch environment (strongly preferred)
* ISM, CIPS, APICS, Lean/Six Sigma certifications preferred. (strongly preferred)
* Strong influencing capabilities and must be able to interact and communicate effectively at all levels of the organization and in a matrix environment
* Knowledge and proficiency with SAP, Oracle, and/or other ERP system (preferred)
* Solid analytical skills and financial acumen
* Strong procurement skills (e.g. negotiation, contracting, supplier management)
* Previous experience negotiating and contracting key operational partnerships
Experience leading cross-functional and global project teams
Demonstrated high degree of independence, requiring minimal supervision from senior management.
* Availability to travel (~5-10%). Will need to travel locally between Seattle Area sites and supplier visits as appropriate.
Why should you apply?
* You will help patients in their fight against serious diseases. Cell therapies represent a significant advancement in cancer treatment technology and patient responses.
* You will be part of a company that encourages excellence and innovation, respects diversity, develops leaders and values its employees.
* Youll get a competitive salary and a great benefits package including a potential performance based annual bonus, family medical allowance, vacation days, life assurance, on-site gym and other amenities
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.